AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

AGMB Account Payables

Amounts the company owes suppliers for goods and services received.

AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB

Account Payables · Q3 FY2025 · quarter ended Sep 2025

Account payables of €7.58M in Q3 FY2025

Q3 FY2025 account payables was €7.58M.

Context

  • Account payables amounted to 4.6% of total assets at the end of Q3 FY2025.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2025
€7.58M— QoQ
Account Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Account Payables history

Currency unavailable · from the balance sheet

No Account Payables data reported for this period type.

Account Payables vs competitors

How AGMB compares with its peers on the latest reported figures

  • Peers report in different currencies, so account payables is compared through growth and share of total assets rather than absolute size.
  • Account payables amounts to 4.6% of total assets for AGMB, versus a peer median of 2.3%.
AGMB Competitors
Account Payables for AGMB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ACRSAclaris Therapeutics, Inc.Mar 2026$14.73M USD+131.8%+8.3%7.4%
ALMSAlumis Inc. Common StockJun 2026$12.8M USD-14.6%+80.4%2.3%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€7.58M EUR——4.6%
ANABAnaptysBio, Inc.Mar 2026$7.52M USD+22.8%+11.6%2.3%
EQEquillium, Inc.Mar 2026$1.3M USD-57.7%-42.5%2.1%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding AGMB) —+4.1%+10.0%2.3%

Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Intrinsic Alpha fair value

Locked

Current Price

$5.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.